Established in 1987, the EuroQol Group initially comprised a network of int
ernational, multilingual and multidisciplinary researchers from seven centr
es in Finland, the Netherlands, Norway, Sweden and the UK, Nowadays, the Gr
oup comprises researchers from Canada, Denmark, Germany, Greece, Japan, New
Zealand, Slovenia, Spain, the LISA and Zimbabwe. The process of shared dev
elopment and local experimentation resulted in EQ-5D, a generic measure of
health status that provides a simple descriptive profile and a single index
value that can be used in the clinical and economic evaluation of health c
are and in population health surveys, Currently, EQ-5D is being widely used
in different countries by clinical researchers in a variety of clinical ar
eas. EQ-5D is also being used by eight out of the first 10 of the top 50 ph
armaceutical companies listed in the annual report of Pharma Business (Nove
mber/ December 1999), Furthermore, EQ-5D is one of the handful of measures
recommended for use in cost-effectiveness analyses by the Washington Panel
on Cost Effectiveness in Health and Medicine. EQ-5D has now been translated
into most major languages with the EuroQol Group closely monitoring the pr
ocess.